Pablo G. Legorreta - Jun 28, 2023 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: CEO, Chairman of the Board, Director, 10%+ Owner
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta
Stock symbol: RPRX
Transactions as of: Jun 28, 2023
Transactions value $: $3,836,768
Form type: 4
Date filed: 6/28/2023, 04:01 PM
Previous filing: Jun 13, 2023
Next filing: Jul 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A ordinary shares	Purchase	$3.84M	+130K	+27.66%	$29.51	600K	Jun 28, 2023	By Legorreta 2023 SR Trust	F1, F2
holding	RPRX	Class A ordinary shares						63.8K	Jun 28, 2023	Direct
holding	RPRX	Class A ordinary shares						460K	Jun 28, 2023	By Legorreta Investments LLC
holding	RPRX	Class A ordinary shares						1.28M	Jun 28, 2023	By GST-Exempt Legorreta 2012 Family Trust
holding	RPRX	Class A ordinary shares						41.3K	Jun 28, 2023	By GST-Exempt Legorreta 2020 Family Trust
holding	RPRX	Class A ordinary shares						10K	Jun 28, 2023	By Child
holding	RPRX	Class A ordinary shares						10K	Jun 28, 2023	By Child
holding	RPRX	Class A ordinary shares						123K	Jun 28, 2023	By IRRA
holding	RPRX	Class A ordinary shares						119K	Jun 28, 2023	By SEP/IRA
holding	RPRX	Class A ordinary shares						1.04M	Jun 28, 2023	By Legorreta Children 2002 Trust
holding	RPRX	Class A ordinary shares						6.93K	Jun 28, 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired by the reporting person in open market transactions as part of the reporting person's previously disclosed intention to purchase up to $50 million of the issuer's Class A ordinary shares, as announced in the issuer's press release on March 27, 2023 regarding the issuer's $1.0 billion share repurchase program.
F2	The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $29.40 to $29.60. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

Content

Represents shares acquired by the reporting person in open market transactions as part of the reporting person's previously disclosed intention to purchase up to $50 million of the issuer's Class A ordinary shares, as announced in the issuer's press release on March 27, 2023 regarding the issuer's $1.0 billion share repurchase program.

The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $29.40 to $29.60. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.